This topic contains a solution. Click here to go to the answer

Author Question: The nurse is reviewing antimalarial drug therapy with a patient and instructs the patient to watch ... (Read 51 times)

xclash

  • Hero Member
  • *****
  • Posts: 681
The nurse is reviewing antimalarial drug therapy with a patient and instructs the patient to watch for and report which potential adverse reactions?
 
  a. Drowsiness
  b. Insomnia
  c. Visual disturbances
  d. Constipation

Question 2

A patient with an intestinal infection that is
 
  positive for the Giardia lamblia organism will be taking an antiprotozoal drug. The nurse will include which information in the teaching plan for this patient?
  a. The urine may become dilute and pale during therapy.
  b. Taking the medications with food reduces gastrointestinal upset.
  c. The medications should be taken on an empty stomach.
  d. The drugs may be discontinued once the diarrhea subsides.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

otokexnaru

  • Sr. Member
  • ****
  • Posts: 314
Answer to Question 1

ANS: C

Answer to Question 2

ANS: B




xclash

  • Member
  • Posts: 681
Reply 2 on: Jul 23, 2018
Gracias!


dawsa925

  • Member
  • Posts: 326
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

Everyone has one nostril that is larger than the other.

Did you know?

It is widely believed that giving a daily oral dose of aspirin to heart attack patients improves their chances of survival because the aspirin blocks the formation of new blood clots.

Did you know?

Approximately one in three babies in the United States is now delivered by cesarean section. The number of cesarean sections in the United States has risen 46% since 1996.

Did you know?

About 3.2 billion people, nearly half the world population, are at risk for malaria. In 2015, there are about 214 million malaria cases and an estimated 438,000 malaria deaths.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

For a complete list of videos, visit our video library